Back to Caligan Partners LP
Q2 2026 13F filing
Updated 27 days ago28 disclosed positions worth $2.1B
Portfolio value
$2.1B
Total holdings
28
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-08-14
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | L LQDA LIQUIDIA CORPORATION | $647.3M | 8.12M | 30.45% | — |
| 2 | R RVMDW REVOLUTION MEDICINES INC | $367.4M | 1.96M | 17.28% | — |
| 3 | A AAVXF ABIVAX SA | $207.6M | 1.56M | 9.77% | — |
| 4 | P PCVX VAXCYTE INC | $127.2M | 2.19M | 5.99% | — |
| 5 | E EXEL EXELIXIS INC | $84.5M | 1.55M | 3.98% | — |
| 6 | T TNGX TANGO THERAPEUTICS INC | $78.2M | 2.50M | 3.68% | — |
| 7 | A AVTX AVALO THERAPEUTICS INC | $58.5M | 3.16M | 2.75% | — |
| 8 | X XENE XENON PHARMACEUTICALS INC | $53.7M | 889.9K | 2.53% | — |
| 9 | A ADMA ADMA BIOLOGICS INC | $47.9M | 5.73M | 2.25% | — |
| 10 | R RVMDW REVOLUTION MEDICINES INC | $47.2M | 251.8K | 2.22% | — |
| 11 | L LBRX LB PHARMACEUTICALS INC | $46.7M | 1.44M | 2.20% | — |
| 12 | I IMCR IMMUNOCORE HLDGS PLC | $43.9M | 1.38M | 2.06% | — |
| 13 | V VRDN VIRIDIAN THERAPEUTICS INC | $40.3M | 2.19M | 1.90% | — |
| 14 | V VOR VOR BIOPHARMA INC | $35.4M | 1.93M | 1.67% | — |
| 15 | S SABSW SAB BIOTHERAPEUTICS INC | $31.1M | 7.97M | 1.46% | — |
| 16 | I IVEVF INVENTIVA SA | $30.9M | 8.16M | 1.45% | — |
| 17 | A AURA AURA BIOSCIENCES INC | $30.5M | 4.30M | 1.44% | — |
| 18 | T TYRA TYRA BIOSCIENCES INC | $25.8M | 807.0K | 1.21% | — |
| 19 | I IRD OPUS GENETICS INC | $25M | 6.08M | 1.18% | — |
| 20 | A ANIK ANIKA THERAPEUTICS INC | $21M | 1.44M | 0.99% | — |
| 21 | S SGMT SAGIMET BIOSCIENCES INC | $19.3M | 2.50M | 0.91% | — |
| 22 | ? N/A ARTIVA BIOTHERAPEUTICS INC | $16.8M | 1.74M | 0.79% | — |
| 23 | F FTH FAETH THERAPEUTICS INC | $15.7M | 629.5K | 0.74% | — |
| 24 | M MBX MBX BIOSCIENCES INC | $11M | 200.0K | 0.52% | — |
| 25 | V VRCA VERRICA PHARMACEUTICALS INC | $5.7M | 923.9K | 0.27% | — |
| 26 | M MGRB AGIOS PHARMACEUTICALS INC | $3.3M | 90.0K | 0.16% | — |
| 27 | A ADMA ADMA BIOLOGICS INC | $2.5M | 300.0K | 0.12% | — |
| 28 | ? N/A CELLECTAR BIOSCIENCES INC | $1.3M | 470.0K | 0.06% | — |